Cargando…

High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma

BACKGROUND: The purpose of the study was to investigate the expression and prognostic value of STAT3 in diffuse large B-cell lymphoma (DLBCL). METHODS: Seventy-four DLBCL patients from 2001 to 2007 were reviewed in the study. The STAT3 expression in their tumor tissues was examined using the immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZL, Wu, YQ, Song, YF, Shi, Zhu, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163635/ https://www.ncbi.nlm.nih.gov/pubmed/21806788 http://dx.doi.org/10.1186/1756-8722-4-31

Ejemplares similares

Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
por: Xavier, Flávia Dias, et al.
Publicado: (2014)

Inhibition of VEGFR2 overcomes venetoclax-resistance in diffuse large B-cell lymphoma cells
por: Shi, Yuanfei, et al.
Publicado: (2022)

Homozygous A polymorphism of the complement C1qA(276) correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP
por: Jin, Xuan, et al.
Publicado: (2012)

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
por: Tang, Jing, et al.
Publicado: (2023)

Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo
por: Damm, Jesper Kofoed, et al.
Publicado: (2015)

The single-cell landscape reveals unique tumor subsets and microenvironments associated with poor clinical outcomes in primary testicular diffuse large B-cell lymphoma
por: Bian, Zhouliang, et al.
Publicado: (2023)

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort
por: Juskevicius, Darius, et al.
Publicado: (2017)

High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma
por: Zhang, Yaping, et al.
Publicado: (2017)

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
por: Sehn, Laurie H., et al.
Publicado: (2020)

The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population
por: Levy, Débora, et al.
Publicado: (2011)

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis
por: Vermaat, Joost S., et al.
Publicado: (2020)

Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
por: Hu, Yunfei, et al.
Publicado: (2014)

Facilitating plasmid nuclear delivery by interfering with the selective nuclear pore barrier
por: Azzam, Ihab, et al.
Publicado: (2019)

Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein purpura nephritis in children
por: Fu, Haidong, et al.
Publicado: (2016)

Favorable prognostic role of IL-26 in HCC patients associated with JAK-STAT3-dependent autophagy
por: Zhao, Qihong, et al.
Publicado: (2021)

A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type
por: Lin, Ningjing, et al.
Publicado: (2013)

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
por: Li, Xin, et al.
Publicado: (2018)

Transient HSP90 inhibition enhances the sensitivity of mantle cell lymphoma to poly (ADP-ribose) polymerase (PARP) inhibitors
por: Shi, Chaowen, et al.
Publicado: (2023)

Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma
por: Zhong, Weijie, et al.
Publicado: (2018)

The cyclic behavior of a cytoplasmic factor controlling nuclear membrane breakdown
por: Wasserman, W. J., et al.
Publicado: (1978)

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
por: Hutchings, Martin, et al.
Publicado: (2021)

Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma
por: Wang, Michael L., et al.
Publicado: (2023)

Coding variants of the interleukin-11 receptor with reduced protein maturation show protease-dependent trans-signaling and transduce normal STAT3 signaling
por: Kespohl, Birte, et al.
Publicado: (2022)

Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients
por: Fei, Yue, et al.
Publicado: (2020)

Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

A new method for cancer detection based on diffusion reflection measurements of targeted gold nanorods
por: Ankri, Rinat, et al.
Publicado: (2012)

Improving CT-guided transthoracic biopsy of mediastinal lesions by diffusion-weighted magnetic resonance imaging
por: Guimarães, Marcos Duarte, et al.
Publicado: (2014)

STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma()
por: Tamma, Roberto, et al.
Publicado: (2019)

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
por: Gaymard, Alexandre, et al.
Publicado: (2021)

Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
por: Liu, Yuanhui, et al.
Publicado: (2019)

Induction of Aberrant Crypt Foci in the Large Intestine of F344 Rats by Oral Administration of 2‐Amino‐l‐methyl‐6‐phenylimidazo[4,5‐b]pyridine
por: Takahashi, Satoru, et al.
Publicado: (1991)

A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
por: Guo, Deliang, et al.
Publicado: (2021)

Nuclear Localization of Immunoreactive β‐Catenin Is Specific to Familial Adenomatous Polyposis in Papillary Thyroid Carcinoma
por: Kurihara, Katsumi, et al.
Publicado: (2000)

Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population
por: Lopes, Lisandro F, et al.
Publicado: (2012)

The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
por: Kim, Seok Jin, et al.
Publicado: (2015)

Genetic analysis of three wild Eurasian eagle-owl subspecies, B. b. kiautschensis, B. b. ussuriensis, and B. b. tibetanus, in Chinese populations
por: Meng, Meng, et al.
Publicado: (2020)

Increased Expression of ras Genes in Non‐Hodgkin's Lymphomas Is not Associated with Oncogenic Activation of Those Genes by Point Mutation
por: Hamatani, Kiyohiro, et al.
Publicado: (1989)

Randomized Clinical Trial of Endovascular Therapy for Acute Large Vessel Occlusion with Large Ischemic Core (RESCUE-Japan LIMIT): Rationale and Study Protocol
por: YOSHIMURA, Shinichi, et al.
Publicado: (2022)

TP53 and XRCC1 polymorphisms and breast cancer prognosis: a case-case study
por: Rodrigues, Marina Silva, et al.
Publicado: (2011)

Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer
por: Ding, Jiayu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_44stqb1pebqoi00jopdm5pcot6